索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]王紫,苏立.左室四极电极在心脏再同步化治疗中的优势[J].国际心血管病杂志,2016,03:151-154.
点击复制

左室四极电极在心脏再同步化治疗中的优势(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2016年03期
页码:
151-154
栏目:
综述
出版日期:
2016-05-20

文章信息/Info

Title:
-
作者:
王紫; 苏立
400010 重庆医科大学附属第二医院心内科
Author(s):
-
关键词:
心脏再同步化治疗; 左室四极电极; 心力衰竭
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2016.03.006
文献标识码:
-
摘要:
成功放置左室起搏电极对于心脏再同步化治疗(CRT/CRT-D)至关重要。与传统起搏电极相比,四极电极具有以下优势:置入成功率较高、能克服膈神经刺激、避免左室高阈值、避免左室心尖部起搏以及导线脱位率较低。
Abstract:
-

参考文献/References

[1] Eriksson H. Heart failure: a growing public health problem[J]. J Intern Med,1995,237(2):135-141.
[2] Cleland JG, Daubert JC, Erdmann E, et al.Cardiac Resynchronization-Heart Failure(CARE-HF)Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure[J]. N Engl J Med,2005,352(15):1539-1549.
[3] Abraham WT, Fisher WG, Smith AL,et al. Cardiac resynchronization in chronic heart failure[J]. N Engl J Med,2002,346(24):1845-1853.
[4] Moss AJ,Hall WJ,Cannom DS,et al.Cardiac-resynchronization therapy for the prevention of heart-failure events[J]. N Engl J Med,2009,361(14):1329-1338.
[5] 朱 华,张 瑜,邱建平. 心脏再同步化治疗充血性心力衰竭的临床分析[J].国际心血管病杂志,2010,37(5),304-305.
[6] Leon R,Abraham WT,Curtis AB,et al.Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study program[J]. J Am Coll Cardiol,2005,46(12):2348-2356.
[7] Forleo GB, Della Rocca DG, Papavasileiou LP,et al.Left ventricular pacing with a new quadripolar transvenous lead for CRT: early results of a prospective comparison with conventional implant outcomes[J]. Heart Rhythm,2011,8(1):31-37.
[8] Biffi M, Moschini C, Bertini M,et al.Phrenic stimulation:a challenge for cardiac resynchronization therapy[J]. Circ Arrhythm Electrophysiol,2009,2(4):402-410.
[9] Tomassoni G,Baker J,Corbisiero R,et al.Postoperative performance of the quartet left ventricular heart lead[J].J Cardiovasc Electrophysiol,2013,24(4):449-456.
[10] Gurevitz O,Nof E, Carasso S,et al.Programmable multiple pacing configurations help to overcome high left ventricular pacing thresholds and avoid phrenic nerve stimulation[J].Pacing?Clin Electrophysiol,2005,28(12):1255-1259.
[11] Champagne J, Healey JS, Krahn AD,et al. The effect of electronic repositioning on left ventricular pacing and phrenic nerve stimulation[J].Europace,2011,13(3):409-415.
[12] Thibault B, Krst E, Ryu K,et al. Pacing electrode selection in a quadripolar left heart lead determines presence or absence of phrenic nerve stimulation[J].Europace,2010,12(5):751-753.
[13] Biffi M, Boriani G. Phrenic stimulation management in CRT patients: are we there yet? [J]. Curr Opin Cardiol,2011,26(1):12-16.
[14] Uslan DZ, Gleva MJ, Warren DK, et al. Cardiovascular implantable electronic device replacement infections and prevention: results from the REPLACE Registry[J]. Pacing Clin Electrophysiol,2012,35:81-87.
[15] Klein N, Klein M, Weglage H,et al.Clinical efficacy of left ventricular pacing vector programmability in cardiac resynchronization therapy defibrillator patients for management of phrenic nerve stimulation and/or elevated left ventricular pacing thresholds: insights from the Efface Phrenic Stim study[J].Europace,2012,14(6):826-832.
[16] Shetty AK,Duckett SG,Bostock J,et al.Initial single-center experience of a quadripolar pacing lead for cardiac resynchronization therapy[J]. Pacing Clin Electrophysiol,2011,34(4):484-489.
[17] Forleo GB,Mantica M,Di Biase L,et al.Clinical and procedural outcome of patients implanted with a quadripolar left ventricular lead: Early results of a prospective multicenter study[J]. Heart Rhythm,2012,9(11):1822-1828.
[18] Mehta PA, Shetty AK, Squirrel M,et al. Elimination of phrenic nerve stimulation occurring during CRT: follow-up in patients implanted with a novel quadripolar pacing lead[J]. J Interv Card Electrophysiol,2012,33(1):43-49.
[19] Biffi M, Exner DV, Crossley GH,et al.Occurrence of phrenic nerve stimulation in cardiac resynchronization therapy patients: The role of left ventricular lead type and placement site[J]. Europace,2013,15(1):77-82.
[20] Seifert M, Schau T, Moeller,et al. Influence of pacing configurations, body mass index, and position of coronary sinus lead on frequency of phrenic nerve stimulation and pacing thresholds under cardiac resynchronization therapy[J]. Europace,2010,12(7):961-967.
[21] Jastrzebski M, Bacior B, Wojciechowska W,et al.Left ventricular lead implantation at a phrenic stimulation site is safe and effective[J]. Europace,2011,13(4):520-525.
[22] Sperzel J,Dänschel W,Gutleben KJ,et al. First prospective, multi-centre clinical experience with a novel left ventricular quadripolar lead[J].Europace,2012,14(3):365-372.
[23] Arias MA, Pachón M, Puchol A, et al.Acute and mid-term outcomes of transvenous implant of a new left ventricular quadripolar lead versus bipolar leads for cardiac resynchronization therapy: results from a single-center prospective database[J].Cardiol J,2012,19(5):470-478.
[24] Biffi M, Bertini M, Ziacchi M,et al.Management of phrenic stimulation in CRT patients over the long term: still an unmet need?[J]. Pacing Clin Electrophysiol,2011,34(10):1201-1208.
[25] Biffi M, Bertini M, Saporito D, et al.Automatic management of left ventricular stimulation: hints for technologic improvement[J].Pacing Clin Electrophysiol,2009,32(3):346-353.
[26] Burri H, Gerritse B, Davenport L,et al. Fluctutations of left ventricular threshold and required safety margin for left ventricular pacing with cardiac resynchronization therapy[J]. Europace,2009,11(7):931-936.
[27] Behar JM, Bostock J, Zhu Li AP,et al.Cardiac resynchronization therapy delivered via a multipolar left ventricular lead is associated with reduced mortality and elimination of phrenic nerve stimulation: long-term follow-up from a multicenter registry[J].J Cardiovasc Electrophysiol,2015,26(5):540-546.
[28] 折剑青,袁祖贻.心脏再同步化治疗的自动阈值管理功能[J].国际心血管病杂志,2014,41(3):148-150.
[29] Alonso C, Leclercq C, D'Allonnes FR, et al. Six year experience of transvenous left ventricular lead implantation for permanent biventricular pacing in patients with advanced heart failure: technical aspects[J].Heart,2001,86(4):405-410.
[30] Valls-Bertault V, Mansourati J, Gilard M, et al. Adverse events with transvenous left ventricular pacing in patients with severe heart failure: early experience from a single centre[J]. Europace,2001,3(1):60-63.
[31] Crossley GH, Biffi M, Johnson B, et al.Performance of a novel left ventricular lead with short bipolar spacing for cardiac resynchronization therapy: primary results of the Attain Performa quadripolar left ventricular lead study[J].Heart Rhythm,2015,12(4):751-758.
[32] Singh JP, Klein HU, Huang DT,et al.Left ventricular lead position and clinical outcome in the multi-center automatic defibrillator implantation trial cardiac resynchronization therapy(MADIT-CRT)trial[J].Circulation,2011,123(11):1159-1166.
[33] Asbach S, Hartmann M, Wengenmayer T, et al.Vector selection of a quadripolar left ventricular pacing lead affects acute hemodynamic response to cardiac resynchronization therapy: a randomized cross-over trial[J].PLoS One,2013,8(6):e67235.
[34] Philippon F,Liu L,Fung JW,et al.Left ventricular three-dimensional quadripolar lead acute clinical study: the LILAC study[J].Pacing Clin Electrophysiol,2015,38(4):438-447.
[35] Parahuleva MS, Chasan R, Soydan N,et al.Quadripolar left ventricular lead in a patient with CRT-D does not overcome phrenic nerve stimulation[J].Clin Med Insights Cardiol,2011,5:45-47.

备注/Memo

备注/Memo:
-
更新日期/Last Update: 2016-05-20